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The hexosamines are a class of amino sugars in which the hydroxyl radicle
attached to the second carbon atom ofthe hexose molecule is replaced by an amino
group. The most important representatives in man of this class-of compounds
are glucosamine and galactosamine. Hexosamines play an important structural
role in the body, being present in the ground substance of all connective tissues as
components of mucopolysaccharides and mucoproteins (Meyer, 1938; Meyer and
Rapport, 1951; Consden, Glynn and Stanier, 1953). They are present in the
blood plasma, where the majority of the hexosamine content is covalently bound
in protein. In normal individuals hexosamines constitute about 10% by weight
of the total plasma protein and the ratio of glucosamine to galactosamine is
approximately 10 to 1. All known glycoproteins contain hexosamines, which
thus occur in a, /?, and y-globulins, macroglobulins, fibrinogen, orosomucoid,
haptoglobins, and numerous other fractions including the blood-group substances
(Putnam), 1965. The level of serum hexosamines is an approximate index of the
total serum glycoprotein content (Winzler, 1960). Hexosamine values in serum
can readily be estimated by a colorimetric technique first described by Elson
and Morgan (1933).
Several studies of serum hexosamine levels in normal individuals have been
made but many of these were based on small numbers of subjects. In a survey
of 80 healthy volunteers (Spiers and Malone, in preparation) we found a mean
hexosaminelevel of 83-9mg./100 ml. with a standarddeviation of ± 8-4 mg./lOOml.
and a 95O% range of 67d1-100-7 mg./lOOml. The serum hexosamine values
found were compatible with a curve of normal distribution. Serial studies in
normal individuals showed that hexosamine levels remain within narrow limits
over periods of many months.
Abnormally high serum hexosamine levels have been demonstrated in patients
suffering from a variety of infective and neoplastic diseases (West, Clarke and
Kennedy, 1938; Weisbrod, 1950; Weiden, 1958; Jakab, 1963). Pannella
and Marinucci (1959) found raised values in epithelial neoplasms with the most
marked elevations occurring in cases of carcinoma of the lung. Raised serum
hexosamine levels were reported in a series of patients with gastric carcinoma
(Scalvini, 1961), and in lupus erythematosus and macroglobulinaemia (Weiden,
1958). High values have also been found in rheumatic fever (Rosenberg and
Schloss, 1949; Kelley, 1952) and in rheumatoid arthritis and asthma (Jimenez
Diaz, Aguirre and Arjona, 1953). There is evidence of increased levels in pneu-
monia (Nilsson, 1937 ; Faber, 1948) and after trauma (West et al., 1938 ; Schla-
mowitz, de Graff and Schubert, 1950; Boas and Peterman, 1953). Weiden
(1960) found that in 5 out of 6 patients with untreated Hodgkin's disease the serumA. S. D. SPIERS AND HELEN F. MALONE
hexosamine level was markedly elevated at over 200 mg./100 ml., and suggested
that this estimation might be a valuable aid in the diagnosis ofHodgkin's disease
Weiden found in 1 patient with Hodgkin's disease who was studied serially that
the serum hexosamine level fell to near-normal after successful treatment with
nitrogen mustard. She suggested that serial estimations might be useful for
following the therapeutic response and for the early detection of recrudescent
activity.
As a raised level of hexosamines in the serum has been reported in a large
number ofapparently unrelated conditions, the diagnostic value ofthis estimation
must be limited. However, like many other investigations, it may prove useful
if only in particular clinical situations, as it appears that relatively few diseases
are associated with gross elevations. On present evidence (Weiden, 1958, 1960)
these include Hodgkin's disease, collagen diseases and macroglobulinaemia.
Apart from a possible value as a diagnostic aid, this alteration of amino sugar
metabolism in disease is of fundamental interest. The group of seemingly un-
related disorders in which the alteration is most marked may possess unsuspected
common factors, or alternatively many separate factors may influence hexosamine
metabolism to bring about similar results. The relative importance of these
factors may vary in different disease states, and thus diseases or groups ofdiseases
may produce characteristic patterns of altered serum hexosamine level. The
present paper reports our investigations ofthis possibility.
PATIENTS.
Blood samples were obtained from hospital patients. Both inpatients and
outpatients were tested. Only patients in whom a diagnosis had been firmly
established by biopsy or necropsy were included in the final results. As many
untreated patients as possible were included in the survey in order to avoid
unpredictable effects of therapy. The patients were on a free diet, as food does
not affect the serum hexosamine level (Weiden, 1958). Where possible, any
concurrent administration of drugs was temporarily interrupted before obtaining
blood samples, as some drugs, including aspirin, may affect the results of hexo-
samine estimation (Spiers and Malone, in preparation).
METHOD
Samples of 10 ml. of venous blood were allowed to clot in chemically clean
centrifuge tubes at room temperature. Serum was removed after clot retraction
and centrifugation. The test requires 1 ml. of serum and the excess from each
sample was stored at -20°C. for reference or repeat estimations. Samples were
processed and the hexosamine content estimated by the method ofWeiden (1958),
modified by the use of a spectrophotometer as previously described (Spiers and
Malone, in preparation).
RESULTS
The results are summarized as a series ofscattergrams (Fig. 1-5).
Malignant lymphoma (Fig. 1.)
There appears to be no significant difference between the patterns obtained
for follicular lymphoma and lymphosarcoma. In both categories a majority of
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patients had serum hexosamine values within the normal range. No difference
is seen between treated and untreated cases. In Hodgkin's disease, only 27% of
all patients or 17% ofthe untreated patients had levels in the normal range. The
highest hexosamine values in the lymphoma group were found in Hodgkin's
disease, which is also the only malignant lymphoma with a substantial number of
readings above 140 mg./100 ml. It is evident from Fig. 1 thatthere is no constant
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FIG. 1.-Results of serumhexosamine estimations inpatients withmalignantlymphoma. F.L.,
follicular lymphoma; L-S., lymphosarcoma; H.D., Hodgkin's disease; R.C.S., reticulum
cell sarcoma. 0, Untreated patients; 0, patients treated by irradiation or chemotherapy.
relation between the hexosamine level and treatment in Hodgkin's disease. In
the category ofreticulum cell sarcoma only 30% of cases had normal hexosamine
values butthenumber ofresults is too small to decidewhetherthisdisease produces
a pattern different from that of follicular lymphoma or lymphosarcoma.
Leaukaemia (Fig. 2.)
Hexosamine levels differing significantly from normal were not found in any
of the patients with chronic lymphatic leukaemia. Only 30% of the cases of
chronic granulocytic leukaemia and none of the cases of chronic granulocytic
leukaemia in acute transformation had normal levels, but the numbers involved
were small. In the acute leukaemia group, a majority of treated patients and
a minority of untreated patients had normal values. This possible effect of
therapy was not apparent in the other types of leukaemia. When the patients488 A. S. D. SPIERS AND HELEN F. MALONE
with acute leukaemia were considered by age rather than treatment status, it
was seen that most of the adult cases (over 15 years old) had elevated values
whereas most of the childhood cases had normal values. There was however an
overlapping of the two groups.
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FIG. 2. Results ofserum hexosamine estimations in patients with leukaemia. C.L.L., chronic
lymphatic leukaemia; C.G.L., chronic granulocytic leukaemia; C.G.L. Ac./Tr., acute
transformation of chronic granulocytic leukaemia; A.L., acute leukaemia. *, Patients
untreated or in frank relapse; 0, patients receiving treatment.
Dysproteinaemias (Fig. 3.)
Most ofthe cases ofy-myeloma and of Bence Jones proteinaemia showed only
slight elevations of the serum hexosamine level, whereas gross elevations were
found in the patients with ,8 2A-myeloma, and with macroglobulinaemia. In the
macroglobulinaemia group, results were similar in patients where the disease
was primary and in those where macroglobulinaemia was secondary to frank
lymphosarcoma. In 1 patient with primary macroglobulinaemia large quantities
of cryoglobulins were present. When these were allowed to precipitate at room
temperature, the hexosamine content of the supernatant serum was 114-6 mg./
100 ml. When the estimation was repeated taking an aliquot from serum kept
at 37° C., the level was 185.6 mg./100 ml., indicating that 38% of the total
hexosamine content, or nearly all the excess hexosamine, was present in the
cryoglobulin fraction.
A group of patients with idiopathic Coombs-positive acquired haemolytic
anaemia was studied because this disease may be an example ofdisturbed globulin
production without neoplasia. These were compared with the results in patients
with haemolytic anaemia due to corpuscular defects (hereditary spherocytosis,
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paroxysmalnocturnalhaemoglobinuria, andhereditarynon-spherocytichaemolytic
anaemia types I and II). In most of these patients the hexosamine value was
normal. There was no difference between the two groups ofhaemolytic anaemias
and no similarity to the patterns of results seen in the patients with myeloma or
macroglobulinaemia.
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FiG. 3.-Results of serum hexosamine estimations in patients with dysproteinaemia. I, y
myeloma; II, ,B 2A-myeloma; III, macroglobulinaemia; IV, cases of haemolytic anaemia,
included for comparison. *, cases of Bence Jones proteinaemia. A, Cases of macro-
globulinaemia secondary to lymphosarcoma. In column IV: 0, Coombs-positive cases;
0, haemolytic anaemia due to various corpuscular defects.
Carcinomas and Melanoma (Fig. 4).
It was not feasible to consider all the epithelial neoplasms as separate groups
according to their very numerous sites of origin. However, carcinomas of the
breast and lung were considered as separate groups because these neoplasms
are common. The miscellaneous group (Fig. 4) includes patients with carcinoma
of oesophagus, stomach, colon, rectum, liver, gallbladder, prostate, and urinary
bladder. Cases ofmelanoma were considered separately because ofthe very high
I I I
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frequency of metastasis in this disease; it was thought that patients with no
clinical metastases might have hexosamine levels similar to those found in patients
with known secondary deposits. When patients with proven metastatic cancer
are considered, there is no difference between the pattern of readings obtained
in any ofthe four groups (Fig. 4, solid circles). Carcinoma ofthe breast or ofthe
lung appears to possess no special propensity to raise the serum hexosamine level
more than other tumours. In the miscellaneous category, no one tumour type
was constantly associated with a particular range of hexosamine values. None
of the tumours investigated showed any constant relation between the size or
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FIG. 4.-Results of serum hexosamine estimations in patients with various neoplasms. MISC.,
neoplasms of varied origin; *, patients with known metastases; 0, patients with no
clinical metastases.
number or sites of metastases and the serum hexosamine level. It appeared that
this value was not a measure of the mass of tumour tissue present in the patient.
In the miscellaneous category the patients with no clinical metastases (Fig. 4,
open circles) had lower hexosamine levels than similar patients with metastases.
In patients with melanoma no such difference was seen; thus the observed and
expected results were similar. Follow-up of the patients with melanoma and no
clinical metastases at the date oftesting is incomplete, but at the time of writing
secondary deposits have become manifest in some ofthese individuals.
Non-neoplastic conditions (Fig. 5.)
Hexosamine estimations were performed on serum from patients with a variety
of infections, including pneumonia, urinary tract infections, rheumatic fever,
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impetigo, cellulitis, chronic bronchitis, tuberculosis and brucellosis. The results
arerepresented by solid circles inthefirst column ofFig. 5. The range ofobserved
values was wide, the majority being above the upper limit of the normal range
but below 150 mg./100 ml. Two of the highest levels recorded were in cases of
extensive cellulitis. The open circles in the first column of Fig. 5 represent the
hexosamine values in a series of patients subjected to lymph node biopsy with a
clinical diagnosis ofmalignant lymphoma, in whom the biopsy specimens showed
reactive changes only without neoplasia. Only one of these results deviates
markedly from the normal, in a patient subsequently found to have infectious
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FIG. 5.-Results of serum hexosamine estimations in patients with non-neopla-stic conditions.
INF., infections; COLL., collagen disease; MONGOLS, patients with Down's syndrome
without other disease; MISC., heterogenous group. Forexplanation ofsymbols in first and
last columns see text.
mononucleosis. No definitive diagnoses were reached in the remaining patients.
The small number of patients with collagen disease included cases of Sj6gren's
syndrome, rheumatoid arthritis and systemic lupus erythematosus. Elevations
of variable degree were found in most patients. A group of mongols without
other diseasewas studiedbecauseDown's syndrome is associatedwith ageneralised
laxity of connective tissue and abnormal hypermobility of joints (Benda, 1950),
and this might indicate an abnormal mucopolysaccharide metabolism. The
results (Fig. 5) suggest that mongols may have a mean value and normal range of
serum hexosamine levels different from that of the general population, which
would be in accord with the results ofa number ofother biochemical investigations
in Down's syndrome (Mellman et al., 1964; Baikie et al,. 1965; Rosner et al.,
1965). No definite conclusions could be drawn from the results of hexosamine
estimations in a miscellaneous group ofnoninfective conditions (Fig. 5, column 4).A. S. D. SPIERS AND HELEN F. MALONE
In patients with burns (represented by solid triangles) levels were usually normal.
Several patients with recent myocardial infarction (represented by open circles)
had slightly elevated values. One out of 4 patients with sarcoidosis (represented
by asterisks) had a raised serum hexosamine, as did 1 out of 4 patients with
myelofibrosis (represented by solid circles). Normal or near-normal levels were
found in a small number ofpatients (not included in the scattergram) with conges-
tive cardiac failure, alcoholic cirrhosis, hepatitis and peptic ulcer.
DISCUSSION
From the results presented it seems certain that the estimation of the serum
hexosamine level can have only limited value as an aid to diagnosis. In every
disease state we have studied there have been some cases with normal hexosamine
levels, thus the finding of a normal value cannot serve to exclude any of these
conditions. Similarly, elevated levels of up to 140 mg./100 ml. were found in
some cases of all the conditions studied except chronic lymphatic leukaemia. It
is obvious that the finding of a hexosamine level in this range cannot aid in
differentiating neoplasms from one another or from infective disease. Such a
result indicates that disease is present but may be as nonspecific as the finding of
an elevated erythrocyte sedimentation rate. When serum hexosamine levels
above 160 mg./100 ml. are considered, many of the cases encountered are likely
to have Hodgkin's disease, / 2A-myeloma, or macroglobulinaemia, but the specifi-
city of this result is still low, as similar levels are recorded in occasional cases of
infection, carcinoma, or collagen disease. Study of a larger series of cases of
myeloma may show the serum hexosamine estimation to have some application
in distinguishing , 2A-myeloma from y -myeloma when facilities for immuno-
electrophoresis or ultracentrifugation are not available. In patients with clinical
features ofHodgkin's disease in whom no histological confirmation can be obtained
from lack of accessible abnormal lymph node tissue, the finding of a serum hexo-
samine level above 160 mg./ 100 ml. might be considered strong supportive
diagnostic evidence. Apart from special clinical situations of this type, the
diagnostic value of the test seems small.
Of more interest is a condiseration of the possible factors underlying the
observed alterations in serum hexosamine levels. In normal individuals the
serum hexosamine content depends principally on the level ofserum glycloproteins
(Winzler, 1960). One possible explanation ofaltered hexosamine levels in disease
is that this is a reflection ofincreased glycoprotein production. In systemic lupus
erythematosus, the hexosamine level is elevated, and falls when the disease
responds to adrenal corticosteroid therapy (Boas and Soffer, 1951). The fall in
hexosamine level correlates with a reduction in hypergammaglobulinaemia
(Boas and Reiner, 1951), and it is therefore reasonable to postulate that the raised
serum hexosamine in this disease is due to an altered plasma protein pattern.
It seems likely that the gross increases of serum hexosamine in cases of /8 2A-
myeloma and macroglobulinaemia are similarly due to excessive production
of an abnormal hexosamine-containing protein. In one patient with macro-
globulinaemia in the present series, it was demonstrated that the excess hexo-
samine separated out from the plasma with the cryoglobulin fraction.
A second possible cause of elevated hexosamine levels in neoplastic disease
was postulated by Shetlar and co-workers (1950) who attributed the rise to active
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cellular proliferation. Gasic and Gasic (1962) have demonstrated the presence
of hexosamines in the cell coating of tumour cells, and it is not unlikely that
rapid proliferation of such tumour cells would result in an increased hexosamine
turnover. This hypothesis does not of course explain the abnormal hexosamine
levels found in several non-neoplastic conditions, nor is it a convincing explanation
of the elevations reported by Pannella and Marinucci (1961) in patients with
benign intestinal polyps.
Cellular necrosis, as well as proliferation, is a feature of many malignant
tumours. Seibert and co-workers (1947) considered that the necrotic processes
in tumours were important in the production of raised serum hexosamine levels,
and Weiden (1958, 1960) thought that the patchy cellular necrosis often seen in
Hodgkin's disease might account for the high values she observed. This hypo-
thesis seems inadequate to explain the frequently elevated hexosamine level in
conditions such as myeloma and acute leukaemia, where extensive cellular necrosis
is not a feature.
One factor common to all the conditions in which raised levels of serum hexo-
samine have been reported is alteration, destruction, or proliferation of connective
tissue, which occurs in infections, trauma, neoplastic infiltration, and collagen
diseases. It is possible that a raised serum hexosamine is simply a nonspecific
index of connective tissue injury and/or repair, as with either process an increased
hexosamine turnover might be reflected by raised blood levels. It has been
shown (Boas and Peterman, 1953) that in animals serum hexosamine levels are
raised during periods of active growth when the mass of mesenchymal tissue is
increasing rapidly, and also after several types of trauma. In infections such
as cellulitis, and after mechanical injury, necrosis and lysis of connective tissue
may release excessive amounts of hexosamines into the circulation. An increased
synthesis of mucopolysaccharides in the ground substance of connective tissue
may be the mechanism ofraised hexosamine levels in proliferative tissue responses.
In rheumatoid arthritis, the proliferation ofsynovial cells may affect the circulating
hexosamine level, as these cells have been shown (Kling, Levine and Wise, 1955;
Grossfield, Meyer and Godman, 1955) to produce free hyaluronic acid.
An explanation of raised serum hexosamine levels in terms of altered connec-
tive tissue metabolism cannot, however, readily account for the observations made
in cases of neoplastic disease. In the present investigation it was striking that
in the patients with cancer the degree ofelevation ofthe hexosamine level appeared
in no way related to the number, extent or size of metastases and hence the degree
of connective tissue involvement. Widely differing values were found in patients
with equal metastatic involvement, even when the same histological type of
tumour was present. Some further factor is needed to explain these findings.
The explanation may lie in the synthetic activity of cells in some tumours. Armin
(1963) has demonstrated the production of large amounts of mucoid material
in cultures of Hodgkin's tissue. If secretory activity of this type occurs in
Hodgkin's disease in vivo, this may well explain why the serum hexosamine in
patients with Hodgkin's disease is frequently higher than in patients with equally
widespread involvement by other lymphomatous neoplasms. Within any one
histological category of neoplasms, differences in the serum hexosamine level
between individual cases mav depend at least as much on the metabolic activities
of the tumour cells as on the total mass of tumour tissue or the extent of tumour
spread in the body.
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SUMMARY
Hexose amino sugars occur in the serum ofnormal individuals in concentrations
ranging from 67-1-100*7 mg./100 ml. Abnormally elevated values occur in a
varietyofdisease states. Aninvestigationhasbeenconductedintothepossiblevalue
ofthe serum hexosamine estimation as a diagnostic aid, and an attempt has been
made to deduce the mechanisms underlying the biochemical disturbance. Hexo-
samine estimations have been performed in 350 patients with leukaemias, malig-
nant lymphomas, carcinomas and a variety of infective diseases, and in a group
of patients with Down's syndrome.
It is concluded that the value of the test in diagnosis is slight, as normal
values occurred in some cases of all the diseases studied, and some elevated
values ofup to 140 mg./100 ml. were found in all the conditions examined except
chronic lymphatic leukaemia. Markedly elevated serum hexosamine levels
(over 160 mg./100 ml.) occurred most frequently in patients with Hodgkin's
disease, macroglobulinaemia, and ft 2A-myeloma, but were also found in occasional
cases ofinfection, carcinoma, and collagen disease.
The results suggest that the serum hexosamine level is affected by multiple
factors whose relative importance varies in different disease states. In macro-
globulinaemia, f 2A-myeloma and systemic lupus erythematosus, elevated
hexosamine levels are probably due to the excessive production of abnormal
glycoproteins. Connective tissue destruction and repair may be the principal
causes of elevated hexosamine values in infection and trauma but do not appear
to have such an important role in cases of malignant disease, where the serum
hexosamine level appears strikingly unrelated to the amount of tumour spread.
It is postulated that in neoplastic disease the production of mucopolysaccharide
substances by the tumour cells is frequently an important factor. Such a mech-
anism would account for the tendency of some histological types of tumour to
regularly produce markedly elevated hexosamine levels and would also explain
the occurrence ofvery high values in occasional cases of other types oftumour.
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